Free shipping on all orders over $ 500

Etomoxir sodium salt

Cat. No. M9075

All AbMole products are for research use only, cannot be used for human consumption.

Etomoxir sodium salt Structure
Synonym:

(R)-(+)-Etomoxir sodium salt

Size Price Availability Quantity
10mM*1mL in DMSO USD 63  USD63 In stock
1mg USD 30  USD30 In stock
5mg USD 60  USD60 In stock
10mg USD 99  USD99 In stock
25mg USD 170  USD170 In stock
50mg USD 300  USD300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Etomoxir((R)-(+)-Etomoxir) sodium salt is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig. Etomoxir is developed as an inhibitor of the mitochondrial carnitine palmitoyltransferase-1 (CPT-1) located on the outer mitochondrial membrane. (R)-(+)-Etomoxir sodium salt is R-form of Etomoxir sodium salt. Etomoxir, in the liver can act as peroxisomal proliferator, increasing DNA synthesis and liver growth. Etomoxir is an inhibitor of free fatty acid (FFA) oxidation-related key enzyme CPT1. Etomoxir has also been identified as a direct agonist of PPARα.

Etomoxir significantly inhibits the decrease of bone mineral density (BMD) and bone breaking strength in db/db and high fat (HF)-fed mice and suppresses the reduction of BMSCs-differentiated osteoblasts. Etomoxir inhibits the increase of mitochondrial ROS generation in db/db and HF-fed mice and osteoblasts.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines Pulmonary artery smooth muscle cells
Preparation method The proliferation of vascular smooth muscle cells was induced by 10–30 ng/mL PDGF-BB. It was shown that the proliferation of PASMCs was also stimulated by PDGF-BB at the similar concentration. After digestion, PASMCs were digested and were cultured in DMEM with 15% FBS. When the cells tended to 80–90% confluences, the medium was replaced by DMEM with 0.02% FBS and starved for 24 h. The cells were pretreated with different doses of ETO (3, 10, 30, 100 µM ETO) for 1 h, and then treated with PDGF-BB (10–30 ng/mL). After incubation for indicated times, PAMSCs were collected and tested.
Concentrations 3, 10, 30, 100, and 300 µM
Incubation time 1 h
Animal Experiment
Animal models male C57BLKS/J lar-Leprdb/db mice
Formulation Saline
Dosages 1 mg/kg twice every week
Administration intraperitoneally injected
Chemical Information
Molecular Weight 320.74
Formula C15H18ClNaO4
CAS Number 828934-41-4
Form Solid
Solubility (25°C) DMSO 45 mg/mL
Water 5 mg/mL
Storage -20°C, protect from light, sealed
References

[1] Wei Zhuang, et al. Mol Cell Biochem. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension

[2] Li J, et al. Sci Rep. FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.

[3] Luiken JJ, et al. Biochem J. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

Related Apoptosis Products
Coenzyme Q0

Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance.

C6 Ceramide

C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway.

DB2115 tertahydrochloride

DB2115 tertahydrochloride is a potent inhibitor of myeloid master regulator PU.1. DB2115 tertahydrochloride has the potential for researching cancers, including hematologic cancers.

14-3-3η Protein inhibitor 1

14-3-3η Protein inhibitor 1 is a 14-3-3η protein inhibitor with a KD of 35 µM.

Deferoxamine

Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Etomoxir sodium salt, (R)-(+)-Etomoxir sodium salt supplier, Apoptosis, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.